Verses AI Inc. (VRSSF)

Verses AI Inc. builds software that thinks more like brains than traditional computers. The company, founded in 2020 and headquartered in Vancouver, Canada, focuses on cognitive computing systems designed to solve the kinds of distributed reasoning problems that most enterprise software gets wrong. Its core approach rests on neuroscience — specifically a principle called active inference that describes how biological brains predict, learn, and act in the world.

The business has two main pieces. The first is AXIOM, which the company positions as its digital brain technology. AXIOM integrates modules for vision, memory, prediction, and reasoning, all built on neuroscience research rather than the pattern-matching rules traditional software relies on. The second is Genius, an intelligence-as-a-service platform launched in April that Verses uses to commercialize AXIOM for enterprise customers. Genius is a network operating system designed to generate what Verses calls a shared world model — a contextualized map of data, policies, simulations, and workflows that intelligent systems can reason over and coordinate across.

The company is early in commercialization but has moved beyond lab work. It inked an enterprise agreement with a major financial institution and ran a successful pilot with Analog, the fleet-management company, which reported a 32 percent improvement in operational performance using Verses’ technology. The company’s approach to funding and growth has been lean by design. In 2024, Verses cut its cash burn by 40 percent while outlining its path to profitability, a move that suggests management expects revenue to scale without constantly raising new capital.

What makes Verses different from other AI companies is that it is not building yet another large language model or a chatbot. Most contemporary AI companies chase pattern-matching at scale. Verses targets reasoning — the ability of software to maintain an internal model of how things actually work and then update that model when the world surprises it. This distinction matters in practice. A call-center chatbot can pattern-match its way to plausible-sounding answers; a fleet-management system or a financial trading system cannot. Those systems need to understand causality and predict consequences. That is what active inference provides, or so the bet goes.

The company’s chief scientist is Karl Friston, one of the world’s most cited neuroscientists, who developed much of the active inference framework. His presence is a signal — Verses is not relying on entrepreneurial guesswork about how brains work, but on decades of research in neuroscience and mathematical biology. That kind of credentialing matters in an AI market crowded with hype, because it moves the burden of proof from marketing claims to published science.

The technology stack itself is proprietary. Verses does not publish its core algorithms and keeps its AXIOM implementation private, which is typical for a young company that views its technology as a defensible moat. The company licenses Genius on a subscription basis to enterprise customers, which creates recurring revenue rather than one-off licensing deals. That recurring model is harder to build than selling software once, but it is the kind of revenue stream that investors reward because it is predictable and compounds as the customer base grows.

Revenue remains small. The company is not yet at the scale where it reports a specific revenue figure in public filings, which tells you the business is still in early stages. Most financial analysis of Verses has to work from the company’s burn rate and cash-on-hand rather than from actual sales. However, the fact that the company attracted enterprise pilots and cut burn while pursuing commercialization suggests the technology is addressing real customer problems rather than solving hypothetical ones.

The risks are substantial. Competitors in cognitive computing and AI are well-funded and move fast. Verses needs to keep ahead of the curve in neuroscience and software engineering simultaneously, which is not a simple task. There is also execution risk — moving from a successful pilot to a repeatable business model requires proving that customers in different industries face the same types of reasoning problems and will pay subscription fees to solve them. The company is betting that active inference will eventually become as foundational to enterprise software as relational databases are now. That bet may be right, but it is still a bet.

The competitive landscape is worth understanding. In cognitive computing and distributed intelligence, Verses faces competition from multiple directions. Traditional AI vendors like IBM and Microsoft are building cognitive capabilities, albeit from different architectural starting points. Newer AI startups are building systems inspired by neuroscience principles, though few have as direct a lineage to published neuroscience research as Verses does. At the same time, enterprises building their own reasoning systems in-house using large language models and prompt engineering represent a form of in-house competition. Verses’ bet is that outsourcing distributed reasoning to a purpose-built platform will eventually be cheaper and more reliable than building it custom, much as outsourcing database management to PostgreSQL was cheaper than building databases in-house. That bet could be right, but it requires the market to recognize the problem first.

The company’s capital structure is modest. Verses has raised money from venture investors and strategic technology partners, but the total capital deployed to date is relatively small compared to the big AI startups that have raised hundreds of millions. That lean approach is both a strength and a risk. Strength, because it means the company has learned to do a lot with limited resources, and proving traction with limited capital is always impressive. Risk, because the company may need significant capital for sales and marketing if the market does not pull the product naturally, and raising that capital gets harder if growth stalls.

The regulatory environment around AI is evolving quickly, but Verses’ approach — enterprise software for reasoning, not consumer applications — sits in a less regulated space than generative AI. That may change. As enterprises deploy cognitive systems to make decisions about loans, hiring, or trading, regulators will inevitably scrutinize how those systems work and whether they can explain their decisions. Verses’ foundation in neuroscience and interpretability might actually be an advantage here, if the company can show that active inference systems are more explainable than black-box neural networks. That is speculative, but it is a possible regulatory moat.

For anyone tracking Verses, the key metrics are customer acquisition, the size of deals relative to burn, and progress toward gross margin targets that prove the software can sustain itself at scale. The company files quarterly 10-Q reports with the SEC under CIK 0001879001. Watch whether the enterprise agreements grow beyond single pilots and whether Genius is adopted across multiple industries. Look for signs that the technology is solving problems that large language models and traditional software cannot solve cost-effectively. If Verses can build a repeatable sales model and keep burn below revenue, the company’s valuation may prove conservative years from now. If it cannot, then the science was interesting but the business was not.